United States Biosimilars of Monoclonal Antibody Industry 2017 Market Research Report

Published: Aug, 2017 | Pages: 111 | Publisher: QYResearch
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

In this report, the United States Biosimilars of Monoclonal Antibody market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Biosimilars of Monoclonal Antibody in these regions, from 2012 to 2022 (forecast).

United States Biosimilars of Monoclonal Antibody market competition by top manufacturers/players, with Biosimilars of Monoclonal Antibody sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Pfizer
    Roche
    Eli Lilly
    Bayer
    Amgen
    Sanofi-Aventis
    Johnson & Johnson
    Novo Nordisk
    Merck
    GSK
    BMS

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into
    Type I
    Type II
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Biosimilars of Monoclonal Antibody for each application, including
    Application 1
    Application 2

If you have any special requirements, please let us know and we will offer you the report as you want.

 Table of Contents

United States Biosimilars of Monoclonal Antibody Market Report 2017
1 Biosimilars of Monoclonal Antibody Overview
    1.1 Product Overview and Scope of Biosimilars of Monoclonal Antibody
    1.2 Classification of Biosimilars of Monoclonal Antibody by Product Category
        1.2.1 United States Biosimilars of Monoclonal Antibody Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Biosimilars of Monoclonal Antibody Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.1 Type I
        1.2.2 Type II
    1.3 United States Biosimilars of Monoclonal Antibody Market by Application/End Users
        1.3.1 United States Biosimilars of Monoclonal Antibody Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.1 Application 1
        1.3.2 Application 2
    1.4 United States Biosimilars of Monoclonal Antibody Market by Region
        1.4.1 United States Biosimilars of Monoclonal Antibody Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
        1.4.3 Southwest Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
        1.4.5 New England Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
        1.4.6 The South Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
        1.4.7 The Midwest Biosimilars of Monoclonal Antibody Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Biosimilars of Monoclonal Antibody (2012-2022)
        1.5.1 United States Biosimilars of Monoclonal Antibody Sales and Growth Rate (2012-2022)
        1.5.2 United States Biosimilars of Monoclonal Antibody Revenue and Growth Rate (2012-2022)

2 United States Biosimilars of Monoclonal Antibody Market Competition by Players/Suppliers
    2.1 United States Biosimilars of Monoclonal Antibody Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Biosimilars of Monoclonal Antibody Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Biosimilars of Monoclonal Antibody Average Price by Players/Suppliers (2012-2017)
    2.4 United States Biosimilars of Monoclonal Antibody Market Competitive Situation and Trends
        2.4.1 United States Biosimilars of Monoclonal Antibody Market Concentration Rate
        2.4.2 United States Biosimilars of Monoclonal Antibody Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Biosimilars of Monoclonal Antibody Manufacturing Base Distribution, Sales Area, Product Type

3 United States Biosimilars of Monoclonal Antibody Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Biosimilars of Monoclonal Antibody Sales and Market Share by Region (2012-2017)
    3.2 United States Biosimilars of Monoclonal Antibody Revenue and Market Share by Region (2012-2017)
    3.3 United States Biosimilars of Monoclonal Antibody Price by Region (2012-2017)

4 United States Biosimilars of Monoclonal Antibody Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Biosimilars of Monoclonal Antibody Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Biosimilars of Monoclonal Antibody Revenue and Market Share by Type (2012-2017)
    4.3 United States Biosimilars of Monoclonal Antibody Price by Type (2012-2017)
    4.4 United States Biosimilars of Monoclonal Antibody Sales Growth Rate by Type (2012-2017)

5 United States Biosimilars of Monoclonal Antibody Sales (Volume) by Application (2012-2017)
    5.1 United States Biosimilars of Monoclonal Antibody Sales and Market Share by Application (2012-2017)
    5.2 United States Biosimilars of Monoclonal Antibody Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Biosimilars of Monoclonal Antibody Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 Roche
        6.2.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 Roche Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Eli Lilly
        6.3.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Eli Lilly Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Bayer
        6.4.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Bayer Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 Amgen
        6.5.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 Amgen Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Sanofi-Aventis
        6.6.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Johnson & Johnson
        6.7.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Johnson & Johnson Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Novo Nordisk
        6.8.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Novo Nordisk Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Merck
        6.9.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Merck Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 GSK
        6.10.2 Biosimilars of Monoclonal Antibody Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 GSK Biosimilars of Monoclonal Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 BMS

7 Biosimilars of Monoclonal Antibody Manufacturing Cost Analysis
    7.1 Biosimilars of Monoclonal Antibody Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Biosimilars of Monoclonal Antibody Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Biosimilars of Monoclonal Antibody Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Biosimilars of Monoclonal Antibody Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Biosimilars of Monoclonal Antibody Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Biosimilars of Monoclonal Antibody Sales Volume Forecast by Type (2017-2022)
    11.3 United States Biosimilars of Monoclonal Antibody Sales Volume Forecast by Application (2017-2022)
    11.4 United States Biosimilars of Monoclonal Antibody Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Biosimilars of Monoclonal Antibody
    Figure United States Biosimilars of Monoclonal Antibody Market Size (K Units) by Type (2012-2022)
    Figure United States Biosimilars of Monoclonal Antibody Sales Volume Market Share by Type (Product Category) in 2016
    Figure United States Biosimilars of Monoclonal Antibody Market Size (K Units) by Application (2012-2022)
    Figure United States Sales Market Share of Biosimilars of Monoclonal Antibody by Application in 2016
    Table Key Downstream Customer in Application 1
    Table Key Downstream Customer in Application 2
    Figure United States Biosimilars of Monoclonal Antibody Market Size (Million USD) by Region (2012-2022)
    Figure The West Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
    Figure Southwest Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Middle Atlantic Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
    Figure New England Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The South of US Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
    Figure The Midwest Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Biosimilars of Monoclonal Antibody Sales (K Units) and Growth Rate (2012-2022)
    Figure United States Biosimilars of Monoclonal Antibody Revenue (Million USD) and Growth Rate (2012-2022)
    Figure United States Biosimilars of Monoclonal Antibody Market Major Players Product Sales Volume (K Units) (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Sales (K Units) of Key Players/Suppliers (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Sales Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Biosimilars of Monoclonal Antibody Sales Share by Players/Suppliers
    Figure 2017 United States Biosimilars of Monoclonal Antibody Sales Share by Players/Suppliers
    Figure United States Biosimilars of Monoclonal Antibody Market Major Players Product Revenue (Million USD) (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Revenue (Million USD) by Players/Suppliers (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Revenue Share by Players/Suppliers (2012-2017)
    Figure 2016 United States Biosimilars of Monoclonal Antibody Revenue Share by Players/Suppliers
    Figure 2017 United States Biosimilars of Monoclonal Antibody Revenue Share by Players/Suppliers
    Table United States Market Biosimilars of Monoclonal Antibody Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
    Figure United States Market Biosimilars of Monoclonal Antibody Average Price (USD/Unit) of Key Players/Suppliers in 2016
    Figure United States Biosimilars of Monoclonal Antibody Market Share of Top 3 Players/Suppliers
    Figure United States Biosimilars of Monoclonal Antibody Market Share of Top 5 Players/Suppliers
    Table United States Players/Suppliers Biosimilars of Monoclonal Antibody Manufacturing Base Distribution and Sales Area
    Table United States Players/Suppliers Biosimilars of Monoclonal Antibody Product Category
    Table United States Biosimilars of Monoclonal Antibody Sales (K Units) by Region (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Sales Share by Region (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Sales Share by Region (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Sales Market Share by Region in 2016
    Table United States Biosimilars of Monoclonal Antibody Revenue (Million USD) and Market Share by Region (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Revenue Share by Region (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Revenue Market Share by Region (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Revenue Market Share by Region in 2016
    Table United States Biosimilars of Monoclonal Antibody Price (USD/Unit) by Region (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Sales (K Units) by Type (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Sales Share by Type (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Sales Share by Type (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Sales Market Share by Type in 2016
    Table United States Biosimilars of Monoclonal Antibody Revenue  (Million USD) and Market Share by Type (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Revenue Share by Type (2012-2017)
    Figure Revenue Market Share of Biosimilars of Monoclonal Antibody by Type (2012-2017)
    Figure Revenue Market Share of Biosimilars of Monoclonal Antibody by Type in 2016
    Table United States Biosimilars of Monoclonal Antibody Price (USD/Unit) by Types (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Sales Growth Rate by Type (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Sales (K Units) by Application (2012-2017)
    Table United States Biosimilars of Monoclonal Antibody Sales Market Share by Application (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Sales Market Share by Application (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Sales Market Share by Application in 2016
    Table United States Biosimilars of Monoclonal Antibody Sales Growth Rate by Application (2012-2017)
    Figure United States Biosimilars of Monoclonal Antibody Sales Growth Rate by Application (2012-2017)
    Table Pfizer Basic Information List
    Table Pfizer Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Pfizer Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Pfizer Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Pfizer Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table Roche Basic Information List
    Table Roche Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Roche Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Roche Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Roche Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table Eli Lilly Basic Information List
    Table Eli Lilly Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Eli Lilly Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Eli Lilly Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Eli Lilly Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table Bayer Basic Information List
    Table Bayer Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Bayer Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Bayer Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Bayer Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table Amgen Basic Information List
    Table Amgen Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Amgen Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Amgen Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Amgen Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table Sanofi-Aventis Basic Information List
    Table Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Sanofi-Aventis Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table Johnson & Johnson Basic Information List
    Table Johnson & Johnson Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Johnson & Johnson Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table Novo Nordisk Basic Information List
    Table Novo Nordisk Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Novo Nordisk Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Novo Nordisk Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Novo Nordisk Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table Merck Basic Information List
    Table Merck Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure Merck Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure Merck Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure Merck Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table GSK Basic Information List
    Table GSK Biosimilars of Monoclonal Antibody Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
    Figure GSK Biosimilars of Monoclonal Antibody Sales Growth Rate (2012-2017)
    Figure GSK Biosimilars of Monoclonal Antibody Sales Market Share in United States (2012-2017)
    Figure GSK Biosimilars of Monoclonal Antibody Revenue Market Share in United States (2012-2017)
    Table BMS Basic Information List
    Table Production Base and Market Concentration Rate of Raw Material
    Figure Price Trend of Key Raw Materials
    Table Key Suppliers of Raw Materials
    Figure Manufacturing Cost Structure of Biosimilars of Monoclonal Antibody
    Figure Manufacturing Process Analysis of Biosimilars of Monoclonal Antibody
    Figure Biosimilars of Monoclonal Antibody Industrial Chain Analysis
    Table Raw Materials Sources of Biosimilars of Monoclonal Antibody Major Players/Suppliers in 2016
    Table Major Buyers of Biosimilars of Monoclonal Antibody
    Table Distributors/Traders List
    Figure United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
    Figure United States Biosimilars of Monoclonal Antibody Revenue  (Million USD) and Growth Rate Forecast (2017-2022)
    Figure United States Biosimilars of Monoclonal Antibody Price (USD/Unit) Trend Forecast (2017-2022)
    Table United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) Forecast by Type (2017-2022)
    Figure United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) Forecast by Type (2017-2022)
    Figure United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) Forecast by Type in 2022
    Table United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) Forecast by Application (2017-2022)
    Figure United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) Forecast by Application (2017-2022)
    Figure United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) Forecast by Application in 2022
    Table United States Biosimilars of Monoclonal Antibody Sales Volume (K Units) Forecast by Region (2017-2022)
    Table United States Biosimilars of Monoclonal Antibody Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Biosimilars of Monoclonal Antibody Sales Volume Share Forecast by Region (2017-2022)
    Figure United States Biosimilars of Monoclonal Antibody Sales Volume Share Forecast by Region in 2022
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

To request a free sample copy of this report, please complete the form below.

Interested in this report? Get your FREE sample now! Get a Free Sample

Did you know?

Our library has over 100000 reports on 1000s of topics

Over 100+ Fortune 500 companies rely on us

90,000+ people come to us for insights every month

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.